These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18524432)

  • 1. High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases.
    Smith KA; Colvin CJ; Weber PS; Spatz SJ; Coussens PM
    Vaccine; 2008 Jul; 26(29-30):3778-82. PubMed ID: 18524432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production.
    Coussens PM; Smith KA; Weber PS; Colvin CJ
    Vaccine; 2011 Nov; 29(47):8661-8. PubMed ID: 21911025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
    Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
    Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of influenza virus replication in Vero and MDCK cell lines.
    Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
    J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Vero cell-derived influenza whole virus vaccine.
    Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
    Dev Biol Stand; 1999; 98():101-10; discussion 111. PubMed ID: 10494963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suitability of MDCK cells grown in a serum-free medium for influenza virus production.
    Kessler N; Thomas-Roche G; Gérentes L; Aymard M
    Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells.
    Govorkova EA; Matrosovich MN; Tuzikov AB; Bovin NV; Gerdil C; Fanget B; Webster RG
    Virology; 1999 Sep; 262(1):31-8. PubMed ID: 10489338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of MDCK cells for production of live attenuated influenza vaccine.
    Liu J; Shi X; Schwartz R; Kemble G
    Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of influenza virus in serum-free mammalian cell cultures.
    Merten OW; Manuguerra JC; Hannoun C; van der Werf S
    Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines.
    van Wielink R; Kant-Eenbergen HC; Harmsen MM; Martens DE; Wijffels RH; Coco-Martin JM
    J Virol Methods; 2011 Jan; 171(1):53-60. PubMed ID: 20933017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale production.
    Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
    Wien Klin Wochenschr; 1999 Mar; 111(5):207-14. PubMed ID: 10226351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of a novel influenza vaccine derived from a continuous cell line].
    Kistner O; Barrett N; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
    ALTEX; 2001; 18(1):50-4. PubMed ID: 11248852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation.
    Saito T; Nakaya Y; Suzuki T; Ito R; Saito T; Saito H; Takao S; Sahara K; Odagiri T; Murata T; Usui T; Suzuki Y; Tashiro M
    J Med Virol; 2004 Oct; 74(2):336-43. PubMed ID: 15332284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent.
    Opitz L; Zimmermann A; Lehmann S; Genzel Y; Lübben H; Reichl U; Wolff MW
    J Virol Methods; 2008 Dec; 154(1-2):61-8. PubMed ID: 18840469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
    George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
    Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine.
    Brands R; Visser J; Medema J; Palache AM; van Scharrenburg GJ
    Dev Biol Stand; 1999; 98():93-100; discussion 111. PubMed ID: 10494962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The growth of attenuated influenza vaccine donor strains in continuous cell lines.
    Audsley JM; Tannock GA
    J Virol Methods; 2005 Feb; 123(2):187-93. PubMed ID: 15620401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical model of influenza A virus production in large-scale microcarrier culture.
    Möhler L; Flockerzi D; Sann H; Reichl U
    Biotechnol Bioeng; 2005 Apr; 90(1):46-58. PubMed ID: 15736163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of reassortant influenza A viruses propagated in serum-free cultured MDCK-SF1 cells.
    Voeten JT; Claas EC; Brands R; Palache AM; van Scharrenburg GJ; Rimmelzwaan GF; Osterhaus AD
    Dev Biol Stand; 1999; 98():77-87; discussion 89-90. PubMed ID: 10494961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.